未登录 Phase II study of pembrolizumab and nab-paclitaxel in HER2-negative metastatic breast cancer: Hormone receptor-positive cohort Novik, Y.; Klar, N.; Zamora, S.; Kwa, M.; Speyer, J.; Oratz, R.; Muggia, F.; Meyers, M.; Hochman, T.; Goldberg, J.; Adams, S. 分享 收藏
分享 收藏
Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma Rose, Peter G.; Java, Janzes J.; Salani, Ritu; Geller, Melissa A.; Secord, Angeles Alvarez; Tewari, Krishnansu S.; Bender, David P.; Mutch, David G.; Friedlander, Michael L.; Van Le, Linda; Method, Michael W.; Hamilton, Chad A.; Lee, Roger B.; Wenham, Robert M.; Guntupalli, Saketh R.; Markman, Maurie; Muggia, Franco M.; Armstron, Deborah K.; Bookman, Michael A.; Burger, Robert A.; Copeland, Lally J. 分享 收藏
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer Kwa, Maryann; Li, Xiaochun; Novik, Yelena; Oratz, Ruth; Jhaveri, Komal; Wu, Jennifer; Gu, Ping; Meyers, Marleen; Muggia, Franco; Speyer, James; Iwano, Alyssa; Bonakdar, Maryam; Kozhaya, Lina; Tavukcuoglu, Ece; Budan, Bahar; Raad, Roy; Goldberg, Judith D.; Unutmaz, Derya; Adams, Sylvia 分享 收藏
Phase II trial of exemestane with immunomodulatory oral cyclophosphamide in metastatic hormone receptor (HR)-positive breast cancer: Prolonged progression-free survival (PFS) in patients with distinct T regulatory cell (Treg) profile Kwa, M.; Novik, Y.; Oratz, R.; Jhaveri, K.; Wu, J.; Gu, P.; Meyers, M.; Muggia, F.; Bonakdar, M.; Abidoglu, C.; Kozhaya, L.; Li, X.; Joseph, B.; Iwano, A.; Friedman, K.; Goldberg, J. D.; Unutmaz, D.; Adams, S. 分享 收藏
Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer Zagar, Timothy M.; Vujaskovic, Zeljko; Formenti, Silvia; Rugo, Hope; Muggia, Franco; O'Connor, Brigid; Myerson, Robert; Stauffer, Paul; Hsu, I-Chow; Diederich, Chris; Straube, William; Boss, Mary-Keara; Boico, Alina; Craciunescu, Oana; Maccarini, Paolo; Needham, David; Borys, Nicholas; Blackwell, Kimberly L.; Dewhirst, Mark W. 分享 收藏
分享 收藏
分享 收藏
Novel targeted therapy for breast cancer chest wall recurrence: Low temperature liposomal doxorubicin and mild local hyperthermia Rugo, H. S.; Zagar, T. M.; Formenti, S. C.; Vujaskovic, Z.; Muggia, F.; O'Connor, B. M.; Myerson, R. J.; Hsu, I. C-C; Borys, N.; Blackwell, K. L.; Dewhirst, M. W. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer 贝伐单抗联合脂质体阿霉素治疗铂类和紫杉类耐药卵巢癌患者的II期研究 Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T.; Blank, S.; Pothuri, B.; Eberhardt, S.; Muggia, F. 分享 收藏
分享 收藏
Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis 小梁蛋白联合聚乙二醇脂质体阿霉素 (PLD) 与PLD在复发性卵巢癌中的比较: 总体生存分析 Monk, Bradley J.; Herzog, Thomas J.; Kaye, Stanley B.; Krasner, Carolyn N.; Vermorken, Jan B.; Muggia, Franco M.; Pujade-Lauraine, Eric; Park, Youn C.; Parekh, Trilok V.; Poveda, Andres M. 分享 收藏